Hosted on MSN

Pfizer’s Tukysa slows breast cancer when added to first-line care

(Bloomberg) -- Pfizer Inc.’s Tukysa, when given as part of the initial treatment for an advanced form of breast cancer, delayed tumor growth by more than eight months, according to a study that may ...

Pfizer CEO Says Company Is Pushing for FDA Priority Review Voucher

Albert Bourla said Pfizer has discussed a fast-pass voucher with the White House during the JPMorgan Healthcare Conference.
Hosted on MSN

Patient dies after taking Pfizer’s drug for blood disorder

(Bloomberg) -- A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of blood disorders. The death occurred on Dec. 14 after the ...
Crain's New York

Pfizer signs license deal with Fosun unit for weight-loss drug

Pfizer has entered into an exclusive global collaboration and licensing deal with a unit of Shanghai Fosun Pharmaceutical for an early-stage weight-loss drug. The agreement with YaoPharma is for the ...